Structure analysis of anode flow field of micro direct methanol fuel cell based on Fluent

微型直接甲醇燃料电池中阳极流场结构对电池的性能有着重要的影响。为了合理设计阳极流场结构,改善甲醇燃料在阳极流场中的分布,采用计算流体动力学(Cfd)软件fluEnT对微型直接甲醇燃料电池进行建模并仿真分析。分析比较了点型、平行和蛇形3种不同流场图案下得到的压降与流速分布,得出蛇形流场能够更有利于甲醇燃料的均匀分配。在此基础上分别建立不同流道宽度(800,400,200,100μM)的蛇形流场模型,通过仿真计算甲醇燃料的分布情况来分析其对燃料电池性能的影响,并结合实验结果进行对比得出流道宽度为200~400μM之间为优化值。Structure of anode flow field is very important for micro direct methanol fuel cell.To optimize the structure of the anode flow field and the distribution of methanol in it,a model of micro direct methanol fuel cell is created and analyzed by using the computational fluid dynamics(CFD) software.The influence of flow field shapes of grid,parallel and serpentine are analyzed and the pressure drop and velocity distribution in the three kinds of flow fields are studied.It shows that the flow field of serpentine is the best for the even distribution of fuel.Based on this,serpentine flow field models with different width(800,400,200 and 100 μm) are created.Simulations are taken to analyze the influence of distribution to cell performance and compared with experimental results,it shows that the optimal value of flow channel width is 200 ~400 μm.国家自然科学基金重点资助项目(60936003

Design and Fabrication of Stack Micro-Direct Methanol Fuel CellUsing Silicon and PDMS

在堆栈式微型直接甲醇燃料电池μ-dMfC(MICrO-dIrECT METHAnOl fuEl CEll)中,为了避免硅基流场板因为封装压力过大而破裂,采用了硅和PdMS(POlydIMETHylSIlOXAnE,聚二甲基硅氧烷)材料分别制作阳极和阴极流场板。首先,采用微机电系统MEMS(MICrO-ElECTrO-MECHAnICAl SySTEMS)技术制作硅基阳极流场板。其次,通过铜箔与阴极流场板一体成型、有机清洗和PdMS表面活化等改进措施显著提升了PdMS阴极流场板金属化的能力。最后,比较和分析阳极流场板上3种不同结构的流道形式的堆栈式μ-dMfC的输出性能。实验结果表明,活化后的PdMS阴极流场板与Cr/Au的粘附性能和粘接强度显著提高,同时阳极流场板的流道一半开设为凸台,一半开设为通孔时,其堆栈式μ-dMfC的输出性能最优。最大输出电流密度为81.25 MA/CM2,最大输出功率为7.73 MW/CM2。采用硅和PdMS材料分别制作流场板,不仅简化了堆栈式μ-dMfC的结构,而且能够缓冲锁紧力,有效保护硅基阳极流场板。同时优化阳极流场板上的流道结构,能够有效提升堆栈式μ-dMfC的输出性能。In order to avoid cracks of the silicon flow field plate caused by high package pressure,silicon and PDMS(Polydimethylsiloxane)are used as anodic and cathode flow field plate respectively in the stack μ-DMFC(Micro-direct methanol fuel cell).The anodic flow field plate based on silicon is fabricated with MEMS(Micro-Electro-Mechanical Systems)technology,and cathode flow field plate is fabricated using PDMS and its metallic performance is evidently improved by means of integral shaping of copper foil and cathode flow field plate,organic cleaning and activation on PDMS surface.The output of stack μ-DMFC is tested and analyzed,in which 3 different flow channel structures on the anodic plate are introduced.Tested results verify that adhesive capability and strengthen between post-activated PDMS and Cr/Au are greatly improved,and when micro blocks and through holes are introduced alternately in the flow channel of anodic flow field plate the stack μ-DMFC can obtain the maximum output,with voltage of 0.5 V,current density of 81.25 mA/cm2 and output power density of 7.73 mW/cm2.This study shows that using silicon and PDMS as flow field plate respectively not only simplifies the structure of stack μ-DMFC but also cushions clamping force and effectively protects anodic flow field plate,and furthermore to increase the output of stack μ-DMFC by optimizing structure of flow channels on the anodic flow field plate.国家自然科学基金重点项目(60936003

Y型聚乙二醇干扰素琢-2b注射液治疗HCV基因2/3型慢性丙型肝炎患者疗效和安全性的多中心随机对照试验研究

目的以标准剂量的聚乙二醇干扰素(Peg IFN)α-2a联合利巴韦林作为阳性对照,评价新型试验药物Y型Peg IFNα-2b注射液联合利巴韦林治疗2型/3型慢性丙型肝炎(CHC)患者的疗效和安全性。方法采用多中心、随机开放、阳性药对照的Ⅲ期临床试验,筛选符合要求的2型/3型CHC患者,按照2:1的比例随机分配到Y型Peg IFNα-2b组和Peg IFNα-2a组,同时口服利巴韦林,疗程24 w,停药随访24 w。采用Abbott Real Time HCV Genotype II检测HCV基因型,采用Cobas Taq Man实时定量PCR法检测血清HCV RNA水平。详细记录不良事件。主要疗效指标为持续病毒学应答(SVR),并进行非劣效检验。结果本试验实际入组2型/3型CHC患者255例,实际治疗241例。全分析集(FAS)数据显示,158例试验组和83例对照组患者SVR分别为85.4%(95%CI 79.94%~90.94%)和79.5%(95%CI 70.84%~88.20%,P=0.2402);对符合方案分析集(PPS)人群分析显示,试验组和对照组患者SVR分别为87.9%(95%CI 82.45%~93.27%)和85.9%(95%CI 77.82%~94.01%,P=0.7060),率差的95%可置信区间均符合非劣效标准;对PPS人群分析显示,85.8%受试者获得了早期病毒学应答(RVR),RVR的阳性预测值为90.1%;试验组和对照组不良事件发生率相似,分别为95.6%和95.2%,严重不良事件发生率分别为3.8%和3.6%。结论应用Peg IFNα联合利巴韦林治疗2型/3型CHC患者,新型试验药物Y型Peg IFNα-2b具有与对照药物Peg IFNα-2a相似的疗效和安全性。国家科技部“十二五”重大专项(编号:2012ZX10002-003)；“重大新药创制”十二五科技重大专项(编号:2012ZX09303019)